» Articles » PMID: 34369883

Interleukin-6 Level is an Independent Predictor of Right Ventricular Systolic Dysfunction in Patients Hospitalized with COVID-19

Overview
Publisher Kare Publishing
Date 2021 Aug 9
PMID 34369883
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Cytokine storm with elevated levels of multiple proinflammatory cytokines and inflammatory system activation underlie the pathogenesis of coronavirus disease 2019 (COVID-19). In this study, we aimed to investigate whether increased interleukin (IL)-6 levels can predict right ventricular (RV) systolic impairment in patients hospitalized with COVID-19.

Methods: This prospective, observational study included 100 consecutive patients hospitalized with mild and moderate COVID-19. All the patients underwent chest computerized tomography, detailed laboratory tests including IL-6, and two dimensional (2D) transthoracic echocardiography (TTE) with assessment of 2D conventional and Doppler echocardiography parameters and RV systolic functions.

Results: After the elimination of six patients with exclusion criteria, the remaining patients were classified into two groups, namely normal RV systolic functions (n=60) and impaired RV systolic functions (n=34). IL-6 levels were significantly higher in patients with impaired RV systolic functions than in those with normal RV systolic functions (20.3, 4.6, p<0.001, respectively). Tricuspid annular plane systolic excursion and RV derived tissue Doppler imaging (TDI) S' measurements were similar between the two groups. RV fractional area change was significantly lower, and RV TDI derived index of myocardial performance was significantly higher in patients with impaired RV systolic functions. In multivariate analysis, IL-6 levels independently predicted deterioration in RV systolic function at a significant level (odds ratio: 1.12, 95% confidence interval: 1.04-1.20, p=0.003).

Conclusion: IL-6 is an independent predictor of RV systolic impairment in patients hospitalized with mild and moderate COVID-19 suggesting a possible pathogenetic mechanism. IL-6 levels can be used to predict RV systolic impairment in patients suffering from this infection.

Citing Articles

Long-term cardio-vascular risk assessment in chronic kidney disease and kidney transplanted patients following SARS-COV-2 disease: protocol for multi-center observational match controlled trial.

Tapoi L, Apetrii M, Dodi G, Nistor I, Voroneanu L, Siriteanu L BMC Nephrol. 2022; 23(1):176.

PMID: 35524223 PMC: 9077937. DOI: 10.1186/s12882-022-02809-4.


Reply to letter to the editor: "Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019".

Erdogan M, Kalem A, Ozturk S, Erdol M, Kayaaslan B, Ozbebek Y Anatol J Cardiol. 2022; 26(2):152.

PMID: 35190368 PMC: 8878914. DOI: 10.5152/AnatolJCardiol.2022.L2.


Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019.

Mungmunpuntipantip R, Wiwanitkit V Anatol J Cardiol. 2022; 26(2):151.

PMID: 35190367 PMC: 8878919. DOI: 10.5152/AnatolJCardiol.2021.973.


The Potential Bioactive Components of Nine TCM Prescriptions Against COVID-19 in Lung Cancer Were Explored Based on Network Pharmacology and Molecular Docking.

Du L, Xiao Y, Xu Y, Chen F, Chu X, Cao Y Front Med (Lausanne). 2022; 8:813119.

PMID: 35127768 PMC: 8811133. DOI: 10.3389/fmed.2021.813119.

References
1.
Repesse X, Vieillard-Baron A . Right heart function during acute respiratory distress syndrome. Ann Transl Med. 2017; 5(14):295. PMC: 5537114. DOI: 10.21037/atm.2017.06.66. View

2.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

3.
Gao Y, Li T, Han M, Li X, Wu D, Xu Y . Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020; 92(7):791-796. PMC: 7228247. DOI: 10.1002/jmv.25770. View

4.
Groot H, Al Ali L, van der Horst I, Schurer R, van der Werf H, Lipsic E . Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction. Clin Res Cardiol. 2018; 108(6):612-621. PMC: 6529378. DOI: 10.1007/s00392-018-1387-z. View

5.
Rana M, Yusuff H, Zochios V . The Right Ventricle During Selective Lung Ventilation for Thoracic Surgery. J Cardiothorac Vasc Anesth. 2019; 33(7):2007-2016. DOI: 10.1053/j.jvca.2018.11.030. View